Pathway enrichment analysis using KEGG indicated significant enrichment (p < 0.05) pathways, including prolactin signaling, oxytocin signaling, GnRH signaling, and central carbon metabolism in cancer (Figure 3E), distinguishing metabolic profiles between high and low prolificacy groups (Table S16). The gene discussed is PRL; the disease is cancer.